Vous avez cherché: hydroxypropanoates (Français - Anglais)

2-hydroxypropanoates de n-(3-diméthylaminopropyl)amides de germes de blé
amides, wheat germ, n-(3-dimethylaminopropyl)-, 2-hydroxypropanoates

152612-69- 6), et ses sels pharmaceutiquement acceptables, - l'acide n-benzyl-r(+)-2-amino-3-hydroxypropanoïque (cas no. 106910-77- 4), et ses sels pharmaceutiquement acceptables, - le r(+)-n-[ (l-méthyl-3-oxo)-l-butén-l-yl]-2-amino-3-hydroxypropanoate d'éthyle et ses sels pharmaceutiquement acceptables, - l'acide r(+)-n-(3-phényl)propyl-2-amino-3-hydroxypropanoïque et ses sels pharmaceutiquement acceptables, - le r(+)-n-(3-phényl)propyl-2-amino-3-hydroxypropanoate d'éthyle et ses sels pharmaceutiquement acceptables, sont particulièrement avantageux pour l'utilisation prévue.
among the above-mentioned derivatives, the following known compounds, with the chemical abstracts service registry number (cas no.) given in brackets, isopropyl r(+)-2-amino-3-hydroxypropanoate (cas no. 117426-05-8) and the pharmaceutically acceptable salts thereof, particularly hydrochloride (cas no. 104055-30-3), benzyl r(+)-2-amino-3-hydroxypropanoate (cas no. 133099-79-3) and pharmaceutically acceptable salts thereof, particularly hydrochloride (cas no. 151651-44-4), n-[r(+)-2-aminopropionyl]-r(+)-2-amino-3-hydroxypropanoic acid (cas no. 61427-68-7), and pharmaceutically acceptable salts thereof, n-[s(−)-2-aminopropionyl]-r(+)-2-amino-3-hydroxypropanoic acid (cas no. 1115-50-0), and pharmaceutically acceptable salts thereof, n-[2-[s(−)-benzyloxycarbonylamino]propionyl]-r(+)-2-amino-3-hydroxypropanoic acid (cas no. 17460-58-1), and pharmaceutically acceptable salts thereof, n-acetyl-r(+)-2-amino-3-hydroxypropanoic acid (cas no. 152612-69-6), and pharmaceutically acceptable salts thereof, n-benzyl-r(+)-2-amino-3-hydroxypropanoic acid (cas no. 106910-77-4), and pharmaceutically acceptable salts thereof, ethyl r(+)-n-[(1-methyl-3-oxo)-1-buten-1-yl]-2-amino-3-hydroxypropanoate and pharmaceutically acceptable salts thereof, r(+)-n-(3-phenyl)propyl-2-amino-3-hydroxypropanoic acid and pharmaceutically acceptable salts thereof, ethyl r(+)-n-(3-phenyl)propyl-2-amino-3-hydroxypropanoate and pharmaceutically acceptable salts thereof, are particularly advantageous for the intended use.